| Product NDC: | 0009-3375 |
| Proprietary Name: | Cleocin Phosphate |
| Non Proprietary Name: | CLINDAMYCIN PHOSPHATE |
| Active Ingredient(s): | 12 mg/mL & nbsp; CLINDAMYCIN PHOSPHATE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0009-3375 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050639 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19900830 |
| Package NDC: | 0009-3375-02 |
| Package Description: | 24 BAG in 1 CARTON (0009-3375-02) > 50 mL in 1 BAG (0009-3375-01) |
| NDC Code | 0009-3375-02 |
| Proprietary Name | Cleocin Phosphate |
| Package Description | 24 BAG in 1 CARTON (0009-3375-02) > 50 mL in 1 BAG (0009-3375-01) |
| Product NDC | 0009-3375 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CLINDAMYCIN PHOSPHATE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19900830 |
| Marketing Category Name | NDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Strength Number | 12 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |